| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cornified envelope | 1.91e-04 | 69 | 34 | 3 | GO:0001533 | |
| Domain | EPHD | 6.03e-04 | 22 | 31 | 2 | PS51805 | |
| Domain | fn3 | 2.41e-03 | 162 | 31 | 3 | PF00041 | |
| Domain | FN3 | 3.50e-03 | 185 | 31 | 3 | SM00060 | |
| Domain | FN3 | 4.30e-03 | 199 | 31 | 3 | PS50853 | |
| Domain | FN3_dom | 4.93e-03 | 209 | 31 | 3 | IPR003961 | |
| Domain | PHD | 9.54e-03 | 89 | 31 | 2 | SM00249 | |
| Domain | ARM-like | 9.96e-03 | 270 | 31 | 3 | IPR011989 | |
| Domain | Znf_PHD | 9.96e-03 | 91 | 31 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.08e-02 | 95 | 31 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.10e-02 | 96 | 31 | 2 | PS01359 | |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 2.46e-06 | 27 | 34 | 3 | 18649358 | |
| Pubmed | The Armadillo family protein p0071 is a VE-cadherin- and desmoplakin-binding protein. | 5.56e-06 | 4 | 34 | 2 | 12426320 | |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 8.87e-06 | 41 | 34 | 3 | 20431927 | |
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 30257991 | ||
| Pubmed | Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains. | 9.26e-06 | 5 | 34 | 2 | 12615965 | |
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 10497212 | ||
| Pubmed | 5.87e-05 | 1049 | 34 | 7 | 27880917 | ||
| Pubmed | Assessment of splice variant-specific functions of desmocollin 1 in the skin. | 7.19e-05 | 13 | 34 | 2 | 14673151 | |
| Pubmed | Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. | 7.19e-05 | 13 | 34 | 2 | 20065295 | |
| Pubmed | 8.38e-05 | 14 | 34 | 2 | 27551807 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.41e-05 | 774 | 34 | 6 | 15302935 | |
| Pubmed | 9.66e-05 | 15 | 34 | 2 | 31903119 | ||
| Pubmed | 1.15e-04 | 497 | 34 | 5 | 23414517 | ||
| Pubmed | 1.41e-04 | 18 | 34 | 2 | 26674342 | ||
| Pubmed | Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism. | 2.53e-04 | 24 | 34 | 2 | 25505152 | |
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 2.53e-04 | 24 | 34 | 2 | 26633881 | |
| Pubmed | 2.74e-04 | 25 | 34 | 2 | 23132931 | ||
| Pubmed | Genomic architecture of Shh-dependent cochlear morphogenesis. | 3.45e-04 | 28 | 34 | 2 | 31488567 | |
| Pubmed | 4.43e-04 | 152 | 34 | 3 | 34299191 | ||
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 4.52e-04 | 32 | 34 | 2 | 23535730 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 7.25e-04 | 180 | 34 | 3 | 35198878 | |
| Pubmed | 9.35e-04 | 46 | 34 | 2 | 18782753 | ||
| Pubmed | 9.41e-04 | 197 | 34 | 3 | 23686814 | ||
| Interaction | TLE3 interactions | 2.59e-06 | 376 | 34 | 7 | int:TLE3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p12 | 4.86e-03 | 140 | 34 | 2 | chr10p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q21 | 4.93e-03 | 141 | 34 | 2 | chr12q21 | |
| GeneFamily | Fibronectin type III domain containing | 8.05e-04 | 160 | 21 | 3 | 555 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 9.91e-06 | 224 | 34 | 5 | M2500 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C6 | 1.63e-05 | 5 | 34 | 2 | M15374 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP | 7.45e-05 | 174 | 34 | 4 | M8947 | |
| Coexpression | GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 9.84e-05 | 187 | 34 | 4 | M8460 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 1.11e-04 | 193 | 34 | 4 | M4284 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 1.18e-04 | 196 | 34 | 4 | M4267 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 1.23e-04 | 198 | 34 | 4 | M4264 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 1.25e-04 | 199 | 34 | 4 | M9253 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.25e-04 | 199 | 34 | 4 | M9180 | |
| Coexpression | GSE17721_CTRL_VS_CPG_6H_BMDC_DN | 1.28e-04 | 200 | 34 | 4 | M3765 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 1.47e-04 | 79 | 34 | 3 | M13387 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.48e-04 | 208 | 34 | 4 | M39233 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 1.79e-04 | 946 | 34 | 7 | M39169 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 2.71e-04 | 97 | 34 | 3 | MM1318 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 2.71e-04 | 97 | 34 | 3 | M2434 | |
| Coexpression | NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE | 2.75e-04 | 19 | 34 | 2 | M41012 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | 3.07e-04 | 726 | 34 | 6 | M4210 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 3.14e-04 | 102 | 34 | 3 | MM872 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 185 | 34 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 188 | 34 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 191 | 34 | 4 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 34 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 8.56e-06 | 189 | 34 | 5 | 1285_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 9.95e-06 | 195 | 34 | 5 | 2122_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.02e-05 | 196 | 34 | 5 | 848_DN | |
| Disease | esophageal adenocarcinoma, digestive system disease, Barrett's esophagus | 1.84e-04 | 18 | 33 | 2 | EFO_0000280, EFO_0000405, EFO_0000478 | |
| Disease | cytotoxicity measurement, response to metformin | 2.51e-04 | 21 | 33 | 2 | EFO_0006952, GO_1901558 | |
| Disease | thrombocytopenia (is_implicated_in) | 4.18e-04 | 27 | 33 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | creatinine measurement | 7.35e-04 | 995 | 33 | 6 | EFO_0004518 | |
| Disease | lysophosphatidylethanolamine measurement | 9.68e-04 | 41 | 33 | 2 | EFO_0010225 | |
| Disease | neuroimaging measurement | 1.07e-03 | 1069 | 33 | 6 | EFO_0004346 | |
| Disease | methadone dose measurement | 2.20e-03 | 62 | 33 | 2 | EFO_0007907 | |
| Disease | breast carcinoma (is_marker_for) | 2.49e-03 | 66 | 33 | 2 | DOID:3459 (is_marker_for) | |
| Disease | fasting blood glucose measurement | 4.00e-03 | 287 | 33 | 3 | EFO_0004465 | |
| Disease | alanine measurement | 4.18e-03 | 86 | 33 | 2 | EFO_0009765 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNSRSSTQMNSYSDS | 141 | Q99569 | |
| MSGASSSEQNNNSYE | 1 | O60825 | |
| QQSDHSSFGLQNTMS | 351 | Q969M2 | |
| MDTDTSQLGFHQSNQ | 411 | Q96GX5 | |
| TLNRMSFSSNLNHYG | 1196 | Q13085 | |
| NFGHNDSTSQMSLNS | 286 | Q9C0I3 | |
| NYMTQTNDQNGTSSL | 431 | Q8TAM1 | |
| HNEFNSSMARSQTNT | 476 | P54762 | |
| HVRDSYSQMQSQAGG | 501 | O43861 | |
| GNSASNSSANMSRAH | 301 | Q6PEV8 | |
| NNSAENHTANSSMAY | 131 | P78318 | |
| MQSSLAARYATQSNH | 221 | Q8IVL0 | |
| NSMHSSPASSNYQQT | 131 | Q6KC79 | |
| TNNDMNQGTSRHFNY | 96 | Q9BX63 | |
| DSNSRYSALNVQHQM | 106 | O00461 | |
| MTTASTSQVRQNYHQ | 1 | P02794 | |
| YCQTGTMSRHQNQNT | 56 | P15924 | |
| MEYNASNISNSRHDS | 576 | A2RUB6 | |
| AGNSSQSTHMTQRDQ | 406 | Q96C10 | |
| NVNAQMYSGSSALHS | 301 | P20749 | |
| SNSRSQQNRHSFMES | 436 | O76039 | |
| TSNYHSSQRSQMDTL | 236 | Q9HC62 | |
| MTSSACNNNNRSYSN | 521 | Q15788 | |
| DNSMDSNIHQRRNSY | 1201 | Q92859 | |
| QANLTASSEGYMHNN | 81 | Q3SXP7 | |
| NSAYNMHSILSNTSA | 471 | Q15172 | |
| SQAPSHMYGNRSNSS | 636 | P55197 | |
| NHTMSSGVNTRYQEQ | 2441 | Q8N2C7 | |
| NRSSYVTQHQRMHTG | 386 | Q8TB69 | |
| MQSFREQSSYHGNQQ | 1 | Q9UGU0 | |
| STIQHGNSGASYNMQ | 511 | Q6UXY8 | |
| SSDHFSGQQENLNSM | 2421 | Q9BXT5 | |
| TERQGQSSHYSQMDR | 406 | Q6XPR3 | |
| QSSHYSQMDRQGQGS | 411 | Q6XPR3 | |
| QSSHYSQMDRQGQSS | 531 | Q6XPR3 | |
| SQMDRQGQSSHYGQT | 536 | Q6XPR3 | |
| GHSQSQMVASASENN | 831 | Q9HD43 |